Latest News about Gene Therapy
Recent news which mentions Gene Therapy
From Benzinga
 
   Braeden Lichti - Investing in Precision Medicine to Yield New Treatments for Neurodegenerative Diseases
   
  
  November 18, 2021
  From PRLog
 
   Bluebird Bio To Withdraw Marketing Of Skysona Gene Therapy In Europe
   
  October 21, 2021
  Tickers 
   BLUE
  
  
  From Benzinga
 
   Sio Gene Shares Gain As Genetic Nerve Cell Disorder Gene Therapy Trial Shows Encouraging Action
   
  October 21, 2021
  Tickers 
   SIOX
  
  
  From Benzinga
 From Benzinga
 
   4D Molecular To Test Its Wet AMD Gene Therapy In Patients
   
  October 06, 2021
  Tickers 
   FDMT
  
  
  From Benzinga
 
   Adverum's Single Dose Wet AMD Gene Therapy Shows Robust Two Year Durability, Safety
   
  October 04, 2021
  Tickers 
   ADVM
  
  
  From Benzinga
 
   Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business
   
  
  
  September 29, 2021
  From Benzinga
 
   Kids Suffer Adverse Reactions In Applied Genetic's Color Blindness Gene Therapy Trial
   
  September 24, 2021
  Tickers 
   AGTC
  
  
  From Benzinga
 
   Verve Therapeutics' Gene-Editing Therapy Shows Encouraging Preclinical Action In Cardiovascular Disease
   
  September 23, 2021
  Tickers 
   VERV
  
  
  From Benzinga
 
   Solid Biosciences Stock Gains After Duchenne Dystrophy Gene Therapy Data
   
  September 23, 2021
  Tickers 
   SLDB
  
  
  From Benzinga
 
   Bluebird Bio Files US Application For β-thalassemia Gene Therapy
   
  September 22, 2021
  Tickers 
   BLUE
  
  
  From Benzinga
 
   Novartis Adds Vision Loss Gene Therapy Program Via Arctos Acquisition
   
  September 21, 2021
  Tickers 
   NVS
  
  
  From Benzinga
 
   Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
   
  September 16, 2021
  Tickers 
   NTLA
  
  
  From Benzinga
 
   Astellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
   
  
  
  September 14, 2021
  From Benzinga
 
   AbbVie, RegenXBio Ink $1.75B Retinal Gene Therapy Collaboration
   
  
  
  September 13, 2021
  From Benzinga
 
   Decibel Therapeutics' Hearing Loss Gene Therapy Receives FDA Orphan Drug Tag
   
  September 09, 2021
  Tickers 
   DBTX
  
  
  From Benzinga
 
   Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy
   
  
  
  September 07, 2021
  From Benzinga
 
   FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
   
  September 07, 2021
  Tickers 
   BMRN
  
  
  From Benzinga
 
   See Why Astellas Stopped Dosing In Neuromuscular Disease Gene Therapy Trial
   
  
  
  September 01, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
